Your browser doesn't support javascript.
loading
Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection.
Nishiguchi, Shuhei; Urano, Yasuhisa; Suzaki, Keiko; Taniguchi, Atsushi; Scherer, Joseph; Berger, Kristi L; Quinson, Anne-Marie; Stern, Jerry O; Omata, Masao.
Afiliação
  • Nishiguchi S; Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
  • Urano Y; Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan.
  • Suzaki K; Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan.
  • Taniguchi A; Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan.
  • Scherer J; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Connecticut, USA.
  • Berger KL; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Connecticut, USA.
  • Quinson AM; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Connecticut, USA.
  • Stern JO; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Connecticut, USA.
  • Omata M; Department of Gastroenterology, Yamanashi Prefectural Central Hospital, Kofu, Japan.
Hepatol Res ; 47(3): E142-E151, 2017 Mar.
Article em En | MEDLINE | ID: mdl-27153246
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article